Costa Rica vs Latvia: 10_Insured export credit exposures, short term
Costa Rica
3.48 billion BU
in 2025
Latvia
3.42 billion BU
in 2025
Costa Rica rank
69th
Latvia rank
70th
10_Insured export credit exposures, short term over time
- Costa Rica
- Latvia
How they compare
Costa Rica currently reports 3.48 billion BU against 3.42 billion BU in Latvia, a difference of 58.00 million BU.
The two have swapped places 5 times across 21 shared years of data; in 2005 it was Latvia ahead.
Costa Rica ranks 69th and Latvia ranks 70th of 211 countries.
Across the 3 decades both report, Costa Rica averaged higher in 1 and Latvia in 2.
Head to head by decade
| Decade | Costa Rica | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 704.00 million BU | 1.13 billion BU | 421.60 million BU | Latvia |
| 2010s | 1.32 billion BU | 1.18 billion BU | 147.70 million BU | Costa Rica |
| 2020s | 2.77 billion BU | 2.91 billion BU | 143.83 million BU | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher 10_insured export credit exposures, short term, Costa Rica or Latvia?
- Costa Rica, at 3.48 billion BU against 3.42 billion BU in Latvia as of 2025.
- What is the difference in 10_insured export credit exposures, short term between Costa Rica and Latvia?
- 58.00 million BU, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Latvia?
- 21 years are reported by both, from 2005 to 2025.
- How do Costa Rica and Latvia rank globally for 10_insured export credit exposures, short term?
- Costa Rica ranks 69th and Latvia ranks 70th of 211 countries.
- Where does this data come from?
- BIS, published as 10_Insured export credit exposures, short term (BU). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
ST refers to insured export credits with credit terms up to and including 12 months, except for transactions involving an insured manufacturing (pre-credit) risk with a risk period of more than 12 months, which are classified as medium/long-term (MLT).